{"title":"对两个数据库进行一致性分析,以搜索肿瘤血液病患者潜在的药物相互作用。","authors":"Pryscila Rodrigues Moreira, Leonardo Teodoro de Farias, Amanda Ribeiro Feitosa, Lunara Teles Silva, Tatyana Xavier Almeida Matteucci Ferreira, Mércia Pandolfo Provin, Rita Goreti Amaral, Ana Carolina Figueiredo Modesto","doi":"10.1177/10781552231225187","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Potential drug interactions exert a significant impact on patient safety, especially within intricate onco-hematological treatments, potentially resulting in toxicity or treatment failures. Despite the availability of databases for potential drug interaction investigation, persistent heterogeneity in concordance rates and classifications exists. The additional variability in database agreement poses further complexity, notably in critical contexts like onco-hematology.</p><p><strong>Aim: </strong>To analyze the concordance of two databases for researching potential drug interaction in prescriptions for hematological patients at a University Hospital in the Midwest region of Brazil.</p><p><strong>Method: </strong>Cross-sectional study developed in a Brazilian hospital. The search for potential drug interaction was conducted in Micromedex® and UpToDate®. The variables were: the presence of potential drug interaction, severity, mechanism, management, and documentation. Data was analyzed in terms of frequency (absolute and relative), Cohen's kappa, and Fleiss kappa<i>.</i></p><p><strong>Results: </strong>The presence of potential drug interaction, showed a lack of concordance between the databases (<i>k</i> = -0.115 [95% CI: 0.361-0.532], <i>p</i> = 0.003). Regarding the mechanism, a strong agreement was observed (<i>k</i> = 0.805, <i>p</i> < 0.001 [95% CI: 0.550-0.941]). The management concordance showed a fair agreement, 46.8% (<i>k</i> = 0.22, <i>p</i> < 0.001 [95% CI: 0.099-0.341]). Stratifying the categories, significant concordance was observed in \"Adjustment of dose + Monitoring\" (<i>k</i> = 0.302, <i>p</i> = 0.018) and \"Monitoring\" (<i>k</i> = 0.417, <i>p</i> = 0.001), while other categories did not reach statistical significance.</p><p><strong>Conclusion: </strong>Our study emphasizes the variability in potential drug interaction research, revealing disparities in severity classification, management recommendations, and documentation practices across databases.</p>","PeriodicalId":16637,"journal":{"name":"Journal of Oncology Pharmacy Practice","volume":" ","pages":"90-97"},"PeriodicalIF":1.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients.\",\"authors\":\"Pryscila Rodrigues Moreira, Leonardo Teodoro de Farias, Amanda Ribeiro Feitosa, Lunara Teles Silva, Tatyana Xavier Almeida Matteucci Ferreira, Mércia Pandolfo Provin, Rita Goreti Amaral, Ana Carolina Figueiredo Modesto\",\"doi\":\"10.1177/10781552231225187\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Potential drug interactions exert a significant impact on patient safety, especially within intricate onco-hematological treatments, potentially resulting in toxicity or treatment failures. Despite the availability of databases for potential drug interaction investigation, persistent heterogeneity in concordance rates and classifications exists. The additional variability in database agreement poses further complexity, notably in critical contexts like onco-hematology.</p><p><strong>Aim: </strong>To analyze the concordance of two databases for researching potential drug interaction in prescriptions for hematological patients at a University Hospital in the Midwest region of Brazil.</p><p><strong>Method: </strong>Cross-sectional study developed in a Brazilian hospital. The search for potential drug interaction was conducted in Micromedex® and UpToDate®. The variables were: the presence of potential drug interaction, severity, mechanism, management, and documentation. Data was analyzed in terms of frequency (absolute and relative), Cohen's kappa, and Fleiss kappa<i>.</i></p><p><strong>Results: </strong>The presence of potential drug interaction, showed a lack of concordance between the databases (<i>k</i> = -0.115 [95% CI: 0.361-0.532], <i>p</i> = 0.003). Regarding the mechanism, a strong agreement was observed (<i>k</i> = 0.805, <i>p</i> < 0.001 [95% CI: 0.550-0.941]). The management concordance showed a fair agreement, 46.8% (<i>k</i> = 0.22, <i>p</i> < 0.001 [95% CI: 0.099-0.341]). Stratifying the categories, significant concordance was observed in \\\"Adjustment of dose + Monitoring\\\" (<i>k</i> = 0.302, <i>p</i> = 0.018) and \\\"Monitoring\\\" (<i>k</i> = 0.417, <i>p</i> = 0.001), while other categories did not reach statistical significance.</p><p><strong>Conclusion: </strong>Our study emphasizes the variability in potential drug interaction research, revealing disparities in severity classification, management recommendations, and documentation practices across databases.</p>\",\"PeriodicalId\":16637,\"journal\":{\"name\":\"Journal of Oncology Pharmacy Practice\",\"volume\":\" \",\"pages\":\"90-97\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oncology Pharmacy Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10781552231225187\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology Pharmacy Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10781552231225187","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
导言:潜在的药物相互作用对患者安全有重大影响,尤其是在复杂的肿瘤血液学治疗中,有可能导致毒性或治疗失败。尽管目前已有用于潜在药物相互作用调查的数据库,但在一致率和分类方面仍存在差异。目的:分析巴西中西部地区一家大学医院用于研究血液病患者处方中潜在药物相互作用的两个数据库的一致性:方法:在巴西一家医院开展横断面研究。在 Micromedex® 和 UpToDate® 中对潜在的药物相互作用进行了搜索。变量包括:潜在药物相互作用的存在、严重程度、机制、管理和记录。数据按频率(绝对和相对)、科恩卡帕和弗莱斯卡帕进行分析:结果:在潜在药物相互作用方面,数据库之间缺乏一致性(k = -0.115 [95% CI: 0.361-0.532], p = 0.003)。在机制方面,观察到很强的一致性(k = 0.805,p k = 0.22,p k = 0.302,p = 0.018),"监测"(k = 0.417,p = 0.001),而其他类别没有达到统计学意义:我们的研究强调了潜在药物相互作用研究的差异性,揭示了不同数据库在严重程度分类、管理建议和记录方法上的差异。
Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients.
Introduction: Potential drug interactions exert a significant impact on patient safety, especially within intricate onco-hematological treatments, potentially resulting in toxicity or treatment failures. Despite the availability of databases for potential drug interaction investigation, persistent heterogeneity in concordance rates and classifications exists. The additional variability in database agreement poses further complexity, notably in critical contexts like onco-hematology.
Aim: To analyze the concordance of two databases for researching potential drug interaction in prescriptions for hematological patients at a University Hospital in the Midwest region of Brazil.
Method: Cross-sectional study developed in a Brazilian hospital. The search for potential drug interaction was conducted in Micromedex® and UpToDate®. The variables were: the presence of potential drug interaction, severity, mechanism, management, and documentation. Data was analyzed in terms of frequency (absolute and relative), Cohen's kappa, and Fleiss kappa.
Results: The presence of potential drug interaction, showed a lack of concordance between the databases (k = -0.115 [95% CI: 0.361-0.532], p = 0.003). Regarding the mechanism, a strong agreement was observed (k = 0.805, p < 0.001 [95% CI: 0.550-0.941]). The management concordance showed a fair agreement, 46.8% (k = 0.22, p < 0.001 [95% CI: 0.099-0.341]). Stratifying the categories, significant concordance was observed in "Adjustment of dose + Monitoring" (k = 0.302, p = 0.018) and "Monitoring" (k = 0.417, p = 0.001), while other categories did not reach statistical significance.
Conclusion: Our study emphasizes the variability in potential drug interaction research, revealing disparities in severity classification, management recommendations, and documentation practices across databases.
期刊介绍:
Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...